1. Home
  2. MWC vs VTVT Comparison

MWC vs VTVT Comparison

Compare MWC & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Micware Co. Ltd. American Depositary Shares

MWC

Micware Co. Ltd. American Depositary Shares

HOLD

Current Price

$1.42

Market Cap

93.9M

Sector

Technology

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$26.66

Market Cap

104.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWC
VTVT
Founded
2003
2015
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.9M
104.9M
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
MWC
VTVT
Price
$1.42
$26.66
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $56.00
AVG Volume (30 Days)
★ 128.0K
16.8K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.78
$20.04
52 Week High
$4.20
$44.00

Technical Indicators

Market Signals
Indicator
MWC
VTVT
Relative Strength Index (RSI) 41.10 35.32
Support Level $1.34 N/A
Resistance Level $1.71 $34.65
Average True Range (ATR) 0.16 1.39
MACD -0.02 -0.15
Stochastic Oscillator 12.22 16.89

Price Performance

Historical Comparison
MWC
VTVT

About MWC Micware Co. Ltd. American Depositary Shares

Micware Co Ltd is a Japan-based provider of software development services and inventive information technology (IT) solutions mainly focused on the automotive and mobility sectors. Its main focus is the development and sale of in-vehicle infotainment (IVI) systems that cover a broad range of modern car functionality from multimedia to navigation, human-machine interface, telematics, and driver assistance. The Group is also engaged in the development of navigation software and location information-based smartphone applications. Its reportable operating segments are: SDV (software-defined vehicles), LBS (location-based service), and Other. Maximum revenue is generated from the SDV segment. Geographically, the Group derives maximum revenue from Japan and the rest from international markets.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: